CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo

Microvascular Research ◽

10.1016/j.mvr.2021.104146 ◽

2021 ◽

Vol 136 ◽

pp. 104146

Author(s):

Handong Dan ◽

Xinlan Lei ◽

Xin Huang ◽

Ning Ma ◽

Yiqiao Xing ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.142 ◽

2015 ◽

Vol 137 ◽

pp. 61

Author(s):

C.L. Schwab ◽

D.P. English ◽

J.D. Black ◽

S. Lopez ◽

S. Bellone ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Erbb Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Erbb Receptor Tyrosine Kinase

Download Full-text

165 AZD2171, a potent VEGF receptor tyrosine kinase inhibitor, combined with mechanistically distinct antitumor therapies in vivo

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80173-3 ◽

2004 ◽

Vol 2 (8) ◽

pp. 52 ◽

Author(s):

S. Wedge ◽

J. Kendrew ◽

P.J. Valentine ◽

S.R. Brave ◽

S. Barnett ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

172 Preclinical profile of ABP309, a potent 2nd generation VEGF receptor tyrosine kinase inhibitor belonging to the class of aminonicotinamides

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80180-0 ◽

2004 ◽

Vol 2 (8) ◽

pp. 54-55

Author(s):

J. Brueggen ◽

G. Bold ◽

R. Cozens ◽

P.W. Manley ◽

J. Mestan ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Download Full-text

Abstract 3270: Combination strategy to circumvent the acquired resistance to VEGF receptor tyrosine kinase inhibitor in M24met melanoma in mice

10.1158/1538-7445.am2011-3270 ◽

2011 ◽

Author(s):

Lianglin Zhang ◽

Maruja E. Lira ◽

Keith A. Ching ◽

Enhong Chen ◽

Tina Lu ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Vegf Receptor ◽

Combination Strategy ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2172-3 ◽

2013 ◽

Vol 72 (1) ◽

pp. 93-100 ◽

Author(s):

Rachel Grossman ◽

Betty Tyler ◽

Michelle A. Rudek ◽

Eugene Kim ◽

Patti Zadnik ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Download Full-text

P-359 Results from a phase I study of the oral VEGF receptor tyrosine kinase inhibitor ZD6474, in patients with solid tumors

Lung Cancer ◽

10.1016/s0169-5002(03)92327-0 ◽

2003 ◽

Vol 41 ◽

pp. S182

Author(s):

Catherine Wheeler ◽

Hironobu Minami ◽

Hiromichi Ebi ◽

Makoto Tahara ◽

Yasutsuna Sasaki ◽

...

Keyword(s):

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Solid Tumors ◽

Receptor Tyrosine Kinase ◽

Phase I Study ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

The Synergistic Action of a VEGF-Receptor Tyrosine-Kinase Inhibitor and a Sensitizing PDGF-Receptor Blocker Depends upon the Stage of Vascular Maturation

Microcirculation ◽

10.1080/10739680701370021 ◽

2007 ◽

Vol 14 (8) ◽

pp. 813-825 ◽

Author(s):

Ruslan Hlushchuk ◽

Oliver Baum ◽

Guenther Gruber ◽

Jeanette Wood ◽

Valentin Djonov

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Synergistic Action ◽

Receptor Blocker ◽

Vegf Receptor ◽

Pdgf Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Vascular Maturation

Download Full-text

A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2014.12.001 ◽

2015 ◽

Vol 14 (1) ◽

pp. 18-24.e1 ◽

Author(s):

Corina N. Oldenhuis ◽

Walter J. Loos ◽

Brooke Esteves ◽

Leni van Doorn ◽

Monette M. Cotreau ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Gastrointestinal Malignancies ◽

Phase Ib ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

41 A potential for combining the rapamycin derivative RAD001 (everolimus) with the EGF/ErbB2/VEGF receptor tyrosine kinase inhibitor AEE788 in human cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80049-1 ◽

2004 ◽

Vol 2 (8) ◽

pp. 16 ◽

Author(s):

C. Stephan ◽

S. Zumstein-Mecker ◽

S. Gerboth ◽

A. Boulay ◽

S. Ruetz ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Human Cancer ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.2530 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 2530-2530 ◽

Author(s):

P. Witteveen ◽

M. Langenberg ◽

H. M. Verheul ◽

J. Roodhart ◽

M. Roelvink ◽

...

Keyword(s):

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Solid Tumors ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Advanced Solid Tumors ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text